Fresh Rounds

ABLi Therapeutics, Inc. funding

ABLi Therapeutics, Inc., a pharmaceuticals company based in Atlanta, GA (founded 2025), filed a Form D with the SEC on January 13, 2026 and reported $1M raised.

Amount raised$1M
Offering size$1M
Filed with the SECJanuary 13, 2026
First saleSeptember 15, 2025
IndustryPharmaceuticals
SecuritiesEquity
LocationAtlanta, GA
Founded2025
Entity typeCorporation
Investors so far10
Minimum investment—
Revenue rangeDecline to Disclose

Other health care rounds in Georgia